Endovascular Aneurysm Repair Market by Indication [Abdominal Aortic Aneurysm {AAA} and Thoracic Aortic Aneurysm {Ascending Aortic Aneurysm, Descending Aortic Aneurysm, Thoracoabdominal Aortic Aneurysm, and Thoracic Arch Aortic Aneurysm}], Site [Infrarenal and Pararenal {Juxtarenal and Suprarenal}], Anatomy [Traditional, and Complex], and Products [Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Grafts] - Global Opportunity Analysis and Industry Forecast, 2017-2023
Endovascular aneurysm repair (EVAR) is a minimally invasive alternative to open surgery for the treatment of abdominal and thoracic aortic aneurysm. The EVAR procedure involves inserting a stent graft within the aneurysm area through a groin (femoral artery). This stent insertion provides a permanent alternative channel for blood flow within the patient’s vasculature, thereby preventing aneurysmal sac from blood flow pressure and rupturing. This procedure is favourable for geriatric patients with arterial diseases and are unfit for major open surgeries due to reduction in risk of conventional methods and their complications. In current scenario, the EVAR procedure is rapidly growing as a preferred treatment option compared to open surgeries for aortic aneurysm, owing to its various advantages, such as potentially improved survival rates and reduced recovery time. The global endovascular aneurysm repair (EVAR) market accounted for $2,327 million in 2016, and is anticipated to reach at $3,580 million by 2023, registering a CAGR of 6.2% from 2017 to 2023.
The factors that drive the market growth are rise in occurrences of aortic aneurysm, growth in geriatric population, technological advancements in the field of EVAR, availability of favourable reimbursements for EVAR procedures and devices, and increase in smoking population. However, the growth of the market is restricted by inflated cost associated with EVAR treatment procedures and lack of awareness among people. Besides, EVAR also constitutes various risks associated with the procedures, such as iliac perforation, aneurysmal rupture, stent stenosis, endoleaks, and endotension. In this regard, several technologies are developed and introduced to meet such challenges leading to market growth. Moreover, the scope of improvement in the technology act as an opportunity for the market players.
The global endovascular aneurysm repair (EVAR) market is segmented based on indication, product, site, and anatomy. On the basis of indication, it is classified into abdominal aortic aneurysm (AAA) and thoracic aortic aneurysm (TAA). The thoracic aortic aneurysm is further divided to ascending, descending, thoracoabdominal, and thoracic arch aortic aneurysm. Based on site, the market is categorised as infrarenal and pararenal. The pararenal market is bifurcated into juxtarenal and suprarenal. In terms of anatomy, the market is classified into traditional and complex. By products, it is divided into percutaneous EVAR, fenestrated EVAR, aortic stents & thoracic aortic aneurysm (TAA) graft, and others.
Geographically, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for the highest market share in the EVAR market in 2016, and is expected to maintain its dominance throughout the forecast period, owing to increase in number of EVAR procedures in U.S. For instance, as per Endologix Inc., in 2013 around 63,000 procedures of EVAR were done in U.S. Furthermore, the U.S. endograft market is growing at a CAGR of 8% per year. However, Asia-Pacific is expected to emerge as a lucrative area with maximum growth potential, owing to the improvement in healthcare facilities, available disposable income, and rapid development in the economic conditions.
The EVAR market players are nursing their product portfolio with interesting next generation and advanced technologies of their own. For instance, Lombard Medical Inc., in 2015 received Japanese Ministry of Health, Labor and Welfare (MHLW) approval for its Aorfix endovascular stent graft with the advanced AorFlex delivery system. Moreover, the company in 2016 received CE approval for its advanced IntelliFlex low profile delivery system for the aorfix endovascular stent graft. This aorfix technology of the company is the only stent graft with global approval to treat AAA. In addition, Endlogix Inc., recently gained Food and Drug Administration (FDA) approval for its percutaneous endograft delivery system and possess a new generation Nellix technology an endovascular sealing product useful in mitigation of all types of endoleak. Hence, product development is the key strategy adopted by market players. The report provides a comprehensive analysis of the key players that operate in the global EVAR market.
KEY MARKET BENEFITS
By Indication
The factors that drive the market growth are rise in occurrences of aortic aneurysm, growth in geriatric population, technological advancements in the field of EVAR, availability of favourable reimbursements for EVAR procedures and devices, and increase in smoking population. However, the growth of the market is restricted by inflated cost associated with EVAR treatment procedures and lack of awareness among people. Besides, EVAR also constitutes various risks associated with the procedures, such as iliac perforation, aneurysmal rupture, stent stenosis, endoleaks, and endotension. In this regard, several technologies are developed and introduced to meet such challenges leading to market growth. Moreover, the scope of improvement in the technology act as an opportunity for the market players.
The global endovascular aneurysm repair (EVAR) market is segmented based on indication, product, site, and anatomy. On the basis of indication, it is classified into abdominal aortic aneurysm (AAA) and thoracic aortic aneurysm (TAA). The thoracic aortic aneurysm is further divided to ascending, descending, thoracoabdominal, and thoracic arch aortic aneurysm. Based on site, the market is categorised as infrarenal and pararenal. The pararenal market is bifurcated into juxtarenal and suprarenal. In terms of anatomy, the market is classified into traditional and complex. By products, it is divided into percutaneous EVAR, fenestrated EVAR, aortic stents & thoracic aortic aneurysm (TAA) graft, and others.
Geographically, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for the highest market share in the EVAR market in 2016, and is expected to maintain its dominance throughout the forecast period, owing to increase in number of EVAR procedures in U.S. For instance, as per Endologix Inc., in 2013 around 63,000 procedures of EVAR were done in U.S. Furthermore, the U.S. endograft market is growing at a CAGR of 8% per year. However, Asia-Pacific is expected to emerge as a lucrative area with maximum growth potential, owing to the improvement in healthcare facilities, available disposable income, and rapid development in the economic conditions.
The EVAR market players are nursing their product portfolio with interesting next generation and advanced technologies of their own. For instance, Lombard Medical Inc., in 2015 received Japanese Ministry of Health, Labor and Welfare (MHLW) approval for its Aorfix endovascular stent graft with the advanced AorFlex delivery system. Moreover, the company in 2016 received CE approval for its advanced IntelliFlex low profile delivery system for the aorfix endovascular stent graft. This aorfix technology of the company is the only stent graft with global approval to treat AAA. In addition, Endlogix Inc., recently gained Food and Drug Administration (FDA) approval for its percutaneous endograft delivery system and possess a new generation Nellix technology an endovascular sealing product useful in mitigation of all types of endoleak. Hence, product development is the key strategy adopted by market players. The report provides a comprehensive analysis of the key players that operate in the global EVAR market.
KEY MARKET BENEFITS
- The study provides an in-depth analysis of the global EVAR market and the current trends and future estimations to elucidate the imminent investment pockets.
- The report presents quantitative analysis of the market from 2016 to 2023 to enable stakeholders to capitalize on the prevailing market opportunities.
- Extensive analysis of the market based on product assists to understand the trends in the industry.
- Key market players and their strategies are thoroughly analyzed to understand the competitive outlook of the industry.
By Indication
- Abdominal Aortic Aneurysm (AAA)
- Thoracic Aortic Aneurysm (TAA)
- Ascending Aortic Aneurysm
- Descending Aortic Aneurysm
- Thoracoabdominal Aortic Aneurysm
- Thoracic Arch Aortic Aneurysm
- Infrarenal
- Pararenal
- Juxtarenal
- Suprarenal
- Traditional
- Complex
- Percutaneous EVAR
- Fenestrated EVAR
- Aortic Stents & TAA graft
- Others
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Thailand
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Turkey
- Saudi Arabia
- Republic of South Africa
- Rest of LAMEA
- Medtronic plc.
- Cook Medical Inc.
- Endologix, Inc.
- Lombard Medical, Inc.
- W. L. Gore & Associates, Inc.
- Cardinal Health Inc.
- C. R. Bard, Inc.
- Merck & Co., Inc.
- Terumo Corporation
- Abbott Laboratories
- Volcano Corporation
- Spectranetics International BV
- AbbVie Inc.
- Bolton Medical Inc.
- Aptus Endosystems Inc.
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY MARKET BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. PORTERS FIVE FORCES ANALYSIS
3.4. REGULATORY FRAMEWORK
3.5. MARKET SHARE ANALYSIS, 2016
3.6. MARKET DYNAMICS
3.6.1. Drivers
3.6.1.1. Rising occurrences of aortic aneurysm
3.6.1.2. Growing geriatric population worldwide
3.6.1.3. Technological advancements in EVAR procedures and devices
3.6.1.4. Availability of favorable reimbursement for EVAR procedures and devices
3.6.2. Restraints
3.6.2.1. High cost associated with treatment procedures
3.6.2.2. Lack of awareness in developing region
3.6.3. Opportunities
3.6.3.1. Improvement in EVAR technologies and devices
CHAPTER 4 ENDOVASCULAR ANEURYSM REPAIR (EVAR), BY INDICATION
4.1. OVERVIEWGLOBAL ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET: INDICATION
4.1.1. Market size and forecast
4.2. ABDOMINAL AORTIC ANEURYSM (AAA)
4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.3. THORACIC AORTIC ANEURYSM (TAA)
4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
4.3.4. Ascending thoracic aortic aneurysm
4.3.4.1. Market size and forecast
4.3.5. Descending thoracic aortic aneurysm
4.3.5.1. Market size and forecast
4.3.6. Thoracic arch aneurysm
4.3.6.1. Market size and forecast
4.3.7. Thoracoabdominal aortic aneurysm (TAAA)
4.3.7.1. Market size and forecast
CHAPTER 5 ENDOVASCULAR ANEURYSM REPAIR MARKET, BY SITE
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. INFRARENAL SITE
5.2.1. Market size and forecast
5.3. PARARENAL
5.3.1. Market size and forecast
5.3.2. Juxtarenal
5.3.2.1. Market size and forecast
5.3.3. Suprarenal
5.3.3.1. Market size and forecast
CHAPTER 6 ENDOVASCULAR ANEURYSM REPAIR MARKET, BY ANATOMY
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. TRADITIONAL
6.2.1. Market size and forecast
6.3. COMPLEX
6.3.1. Market size and forecast
CHAPTER 7 ENDOVASCULAR ANEURYSM REPAIR MARKET, BY PRODUCT
7.1. OVERVIEW
7.1.1. Market size and forecast
7.2. PERCUTANEOUS EVAR
7.2.1. Market size and forecast
7.3. FENESTRATED EVAR
7.3.1. Market size and forecast
7.4. AORTIC STENT & TAA GRAFT
7.4.1. Market size and forecast
7.5. OTHERS
7.5.1. Market size and forecast
CHAPTER 8 ENDOVASCULAR ANEURYSM REPAIR MARKET, BY GEOGRAPHY
8.1. OVERVIEW
8.1.1. Market size and forecast
8.2. NORTH AMERICA
8.2.1. Key market trends
8.2.2. Key growth factors and opportunities
8.2.3. Market size and forecast
8.2.3.1. U.S. market size and forecast
8.2.3.2. Mexico market size and forecast
8.2.3.3. Canada market size and forecast
8.3. EUROPE
8.3.1. Key market trends
8.3.2. Key growth factors and opportunities
8.3.3. Market size and forecast
8.3.3.1. UK market size and forecast
8.3.3.2. France market size and forecast
8.3.3.3. Germany market size and forecast
8.3.3.4. Italy market size and forecast
8.3.3.5. Spain market size and forecast
8.3.3.6. Rest of Europe market size and forecast
8.4. ASIA-PACIFIC
8.4.1. Key market trends
8.4.2. Key growth factors and opportunities
8.4.3. Market size and forecast
8.4.3.1. India market size and forecast
8.4.3.2. Japan market size and forecast
8.4.3.3. China market size and forecast
8.4.3.4. Australia market size and forecast
8.4.3.5. South Korea market size and forecast
8.4.3.6. Thailand market size and forecast
8.4.3.7. Rest of Asia-Pacific market size and forecast
8.5. LAMEA
8.5.1. Key market trends
8.5.2. Key growth factors and opportunities
8.5.3. Market size and forecast
8.5.3.1. Brazil market size and forecast
8.5.3.2. South Africa market size and forecast
8.5.3.3. Saudi Arabia market size and forecast
8.5.3.4. Turkey market size and forecast
8.5.3.5. Rest of LAMEA market size and forecast
CHAPTER 9 COMPANY PROFILES
9.1. MEDTRONIC PLC
9.1.1. Company overview
9.1.2. Company snapshot
9.1.3. Operating business segments
9.1.4. Business performance
9.1.5. Key strategic moves and developments
9.2. COOK MEDICAL INC.
9.2.1. Company overview
9.2.2. Company snapshot
9.2.3. Operating business segments
9.2.4. Business performance
9.2.5. Key strategic moves and developments
9.3. ENDOLOGIX INC.
9.3.1. Company overview
9.3.2. Company snapshot
9.3.3. Operating business segments
9.3.4. Business performance
9.3.5. Key strategic moves and developments
9.4. W. L. GORE & ASSOCIATES, INC.
9.4.1. Company overview
9.4.2. Company snapshot
9.4.3. Operating business segments
9.4.4. Business performance
9.4.5. Key strategic moves and developments
9.5. CARDINAL HEALTH INC.
9.5.1. Company overview
9.5.2. Company snapshot
9.5.3. Operating business segments
9.5.4. Business performance
9.5.5. Key strategic moves and developments
9.6. C. R. BARD, INC.
9.6.1. Company overview
9.6.2. Company snapshot
9.6.3. Operating business segments
9.6.4. Business performance
9.6.5. Key strategic moves and developments
9.7. MERCK & CO., INC.
9.7.1. Company overview
9.7.2. Company snapshot
9.7.3. Operating business segments
9.7.4. Business performance
9.7.5. Key strategic moves and developments
9.8. LOMBARD MEDICAL, INC.
9.8.1. Company overview
9.8.2. Company snapshot
9.8.3. Operating business segments
9.8.4. Business performance
9.8.5. Key strategic moves and developments
9.9. TERUMO CORPORATION
9.9.1. Company overview
9.9.2. Company snapshot
9.9.3. Operating business segments
9.9.4. Business performance
9.9.5. Key strategic moves and developments
9.10. ABBOTT LABORATORIES
9.10.1. Company overview
9.10.2. Company snapshot
9.10.3. Operating business segments
9.10.4. Business performance
9.10.5. Key strategic moves and developments
1.1. REPORT DESCRIPTION
1.2. KEY MARKET BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. PORTERS FIVE FORCES ANALYSIS
3.4. REGULATORY FRAMEWORK
3.5. MARKET SHARE ANALYSIS, 2016
3.6. MARKET DYNAMICS
3.6.1. Drivers
3.6.1.1. Rising occurrences of aortic aneurysm
3.6.1.2. Growing geriatric population worldwide
3.6.1.3. Technological advancements in EVAR procedures and devices
3.6.1.4. Availability of favorable reimbursement for EVAR procedures and devices
3.6.2. Restraints
3.6.2.1. High cost associated with treatment procedures
3.6.2.2. Lack of awareness in developing region
3.6.3. Opportunities
3.6.3.1. Improvement in EVAR technologies and devices
CHAPTER 4 ENDOVASCULAR ANEURYSM REPAIR (EVAR), BY INDICATION
4.1. OVERVIEWGLOBAL ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET: INDICATION
4.1.1. Market size and forecast
4.2. ABDOMINAL AORTIC ANEURYSM (AAA)
4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.3. THORACIC AORTIC ANEURYSM (TAA)
4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
4.3.4. Ascending thoracic aortic aneurysm
4.3.4.1. Market size and forecast
4.3.5. Descending thoracic aortic aneurysm
4.3.5.1. Market size and forecast
4.3.6. Thoracic arch aneurysm
4.3.6.1. Market size and forecast
4.3.7. Thoracoabdominal aortic aneurysm (TAAA)
4.3.7.1. Market size and forecast
CHAPTER 5 ENDOVASCULAR ANEURYSM REPAIR MARKET, BY SITE
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. INFRARENAL SITE
5.2.1. Market size and forecast
5.3. PARARENAL
5.3.1. Market size and forecast
5.3.2. Juxtarenal
5.3.2.1. Market size and forecast
5.3.3. Suprarenal
5.3.3.1. Market size and forecast
CHAPTER 6 ENDOVASCULAR ANEURYSM REPAIR MARKET, BY ANATOMY
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. TRADITIONAL
6.2.1. Market size and forecast
6.3. COMPLEX
6.3.1. Market size and forecast
CHAPTER 7 ENDOVASCULAR ANEURYSM REPAIR MARKET, BY PRODUCT
7.1. OVERVIEW
7.1.1. Market size and forecast
7.2. PERCUTANEOUS EVAR
7.2.1. Market size and forecast
7.3. FENESTRATED EVAR
7.3.1. Market size and forecast
7.4. AORTIC STENT & TAA GRAFT
7.4.1. Market size and forecast
7.5. OTHERS
7.5.1. Market size and forecast
CHAPTER 8 ENDOVASCULAR ANEURYSM REPAIR MARKET, BY GEOGRAPHY
8.1. OVERVIEW
8.1.1. Market size and forecast
8.2. NORTH AMERICA
8.2.1. Key market trends
8.2.2. Key growth factors and opportunities
8.2.3. Market size and forecast
8.2.3.1. U.S. market size and forecast
8.2.3.2. Mexico market size and forecast
8.2.3.3. Canada market size and forecast
8.3. EUROPE
8.3.1. Key market trends
8.3.2. Key growth factors and opportunities
8.3.3. Market size and forecast
8.3.3.1. UK market size and forecast
8.3.3.2. France market size and forecast
8.3.3.3. Germany market size and forecast
8.3.3.4. Italy market size and forecast
8.3.3.5. Spain market size and forecast
8.3.3.6. Rest of Europe market size and forecast
8.4. ASIA-PACIFIC
8.4.1. Key market trends
8.4.2. Key growth factors and opportunities
8.4.3. Market size and forecast
8.4.3.1. India market size and forecast
8.4.3.2. Japan market size and forecast
8.4.3.3. China market size and forecast
8.4.3.4. Australia market size and forecast
8.4.3.5. South Korea market size and forecast
8.4.3.6. Thailand market size and forecast
8.4.3.7. Rest of Asia-Pacific market size and forecast
8.5. LAMEA
8.5.1. Key market trends
8.5.2. Key growth factors and opportunities
8.5.3. Market size and forecast
8.5.3.1. Brazil market size and forecast
8.5.3.2. South Africa market size and forecast
8.5.3.3. Saudi Arabia market size and forecast
8.5.3.4. Turkey market size and forecast
8.5.3.5. Rest of LAMEA market size and forecast
CHAPTER 9 COMPANY PROFILES
9.1. MEDTRONIC PLC
9.1.1. Company overview
9.1.2. Company snapshot
9.1.3. Operating business segments
9.1.4. Business performance
9.1.5. Key strategic moves and developments
9.2. COOK MEDICAL INC.
9.2.1. Company overview
9.2.2. Company snapshot
9.2.3. Operating business segments
9.2.4. Business performance
9.2.5. Key strategic moves and developments
9.3. ENDOLOGIX INC.
9.3.1. Company overview
9.3.2. Company snapshot
9.3.3. Operating business segments
9.3.4. Business performance
9.3.5. Key strategic moves and developments
9.4. W. L. GORE & ASSOCIATES, INC.
9.4.1. Company overview
9.4.2. Company snapshot
9.4.3. Operating business segments
9.4.4. Business performance
9.4.5. Key strategic moves and developments
9.5. CARDINAL HEALTH INC.
9.5.1. Company overview
9.5.2. Company snapshot
9.5.3. Operating business segments
9.5.4. Business performance
9.5.5. Key strategic moves and developments
9.6. C. R. BARD, INC.
9.6.1. Company overview
9.6.2. Company snapshot
9.6.3. Operating business segments
9.6.4. Business performance
9.6.5. Key strategic moves and developments
9.7. MERCK & CO., INC.
9.7.1. Company overview
9.7.2. Company snapshot
9.7.3. Operating business segments
9.7.4. Business performance
9.7.5. Key strategic moves and developments
9.8. LOMBARD MEDICAL, INC.
9.8.1. Company overview
9.8.2. Company snapshot
9.8.3. Operating business segments
9.8.4. Business performance
9.8.5. Key strategic moves and developments
9.9. TERUMO CORPORATION
9.9.1. Company overview
9.9.2. Company snapshot
9.9.3. Operating business segments
9.9.4. Business performance
9.9.5. Key strategic moves and developments
9.10. ABBOTT LABORATORIES
9.10.1. Company overview
9.10.2. Company snapshot
9.10.3. Operating business segments
9.10.4. Business performance
9.10.5. Key strategic moves and developments
LIST OF TABLES
TABLE 1. GLOBAL ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, BY INDICATION, 2017-2023 ($MILLION)
TABLE 2. GLOBAL ABDOMINAL AORTIC ANEURYSM (AAA) MARKET, BY REGION, 2017-2023 ($MILLION)
TABLE 3. GLOBAL THORACIC AORTIC ANEURYSM (TAA) MARKET, BY TYPE, 2017-2023 ($MILLION)
TABLE 4. GLOBAL ASCENDING AORTIC ANEURYSM MARKET, BY REGION, 2017-2023 ($MILLION)
TABLE 5. GLOBAL DESCENDING AORTIC ANEURYSM MARKET, BY REGION, 2017-2023 ($MILLION)
TABLE 6. GLOBAL THORACIC ARCH ANEURYSM MARKET, BY REGION, 2017-2023 ($MILLION)
TABLE 7. GLOBAL THORACIC ARCH ANEURYSM MARKET, BY REGION, 2017-2023 ($MILLION)
TABLE 8. GLOBAL ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, BY SITE, 2017-2023 ($MILLION)
TABLE 9. GLOBAL EVAR INFRARENAL SITE MARKET, BY REGION, 2017-2023 ($MILLION)
TABLE 10. GLOBAL EVAR PARARENAL SITE MARKET, BY TYPE, 2017-2023 ($MILLION)
TABLE 11. GLOBAL EVAR JUXTARENAL SITE MARKET, BY REGION, 2017-2023 ($MILLION)
TABLE 12. GLOBAL EVAR SUPRARENAL SITE MARKET, BY REGION, 2017-2023 ($MILLION)
TABLE 13. GLOBAL ENDOVADCULAR ANEURYSM REPAIR MARKET, BY ANATOMY, 2017-2023 ($MILLION)
TABLE 14. GLOBAL EVAR MARKET FOR TRADITIONAL ANATOMY, BY REGION, 2017-2023 ($MILLION)
TABLE 15. GLOBAL EVAR MARKET FOR COMPLEX ANATOMY, BY REGION, 2017-2023 ($MILLION)
TABLE 16. GLOBAL ENDOVASCULAR ANEURYSM REPAIR MARKET, BY PRODUCT, 2017-2023 ($MILLION)
TABLE 17. GLOBAL PERCUTANEOUS EVAR MARKET, BY REGION, 2017-2023 ($MILLION)
TABLE 18. GLOBAL FENESTRATED EVAR MARKET, BY REGION, 2017-2023 ($MILLION)
TABLE 19. GLOBAL EVAR MARKET FOR AORTIC STENT & TAA GRAFT, BY REGION, 2017-2023 ($MILLION)
TABLE 20. GLOBAL EVAR MARKET FOR OTHER PRODUCTS, BY REGION, 2017-2023 ($MILLION)
TABLE 21. ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, BY REGION, 2017-2023 ($MILLION)
TABLE 22. NORTH AMERICA ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, BY COUNTRY, 2017-2023 ($MILLION)
TABLE 23. NORTH AMERICA ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, BY SITE, 2017-2023 ($MILLION)
TABLE 24. NORTH AMERICA ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, BY ANATOMY, 2017-2023 ($MILLION)
TABLE 25. NORTH AMERICA ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, BY PRODUCT, 2017-2023 ($MILLION)
TABLE 26. EUROPE ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, BY COUNTRY, 2017-2023 ($MILLION)
TABLE 27. EUROPE ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, BY SITE, 2017-2023 ($MILLION)
TABLE 28. EUROPE ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, BY ANATOMY, 2017-2023 ($MILLION)
TABLE 29. EUROPE ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, BY PRODUCT, 2017-2023 ($MILLION)
TABLE 30. ASIA-PACIFIC ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, BY COUNTRY, 2017-2023 ($MILLION)
TABLE 31. ASIA-PACIFIC ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, BY SITE, 2017-2023 ($MILLION)
TABLE 32. ASIA-PACIFIC ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, BY ANATOMY, 2017-2023 ($MILLION)
TABLE 33. ASIA-PACIFIC ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, BY PRODUCT, 2017-2023 ($MILLION)
TABLE 34. LAMEA ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, BY COUNTRY, 2017-2023 ($MILLION)
TABLE 35. LAMEA ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, BY SITE, 2017-2023 ($MILLION)
TABLE 36. LAMEA ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, BY ANATOMY, 2017-2023 ($MILLION)
TABLE 37. LAMEA ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, BY PRODUCT, 2017-2023 ($MILLION)
TABLE 38. MEDTRONIC: COMPANY SNAPSHOT
TABLE 39. MEDTRONIC: OPERATING SEGMENTS
TABLE 40. COOK: COMPANY SNAPSHOT
TABLE 41. COOK: OPERATING SEGMENTS
TABLE 42. ENDOLOGIX: COMPANY SNAPSHOT
TABLE 43. ENDOLOGIX: OPERATING SEGMENTS
TABLE 44. GORE: COMPANY SNAPSHOT
TABLE 45. GORE: OPERATING SEGMENTS
TABLE 46. CARDINAL: COMPANY SNAPSHOT
TABLE 47. CARDINAL: OPERATING SEGMENTS
TABLE 48. C. R. BARD: COMPANY SNAPSHOT
TABLE 49. C. R. BARD: OPERATING SEGMENTS
TABLE 50. MERCK: COMPANY SNAPSHOT
TABLE 51. MERCK: OPERATING SEGMENTS
TABLE 52. LOMBARD: COMPANY SNAPSHOT
TABLE 53. LOMBARD: OPERATING SEGMENTS
TABLE 54. TERUMO: COMPANY SNAPSHOT
TABLE 55. TERUMO: OPERATING SEGMENTS
TABLE 56. ABBOTT: COMPANY SNAPSHOT
TABLE 57. ABBOTT: OPERATING SEGMENTS
TABLE 1. GLOBAL ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, BY INDICATION, 2017-2023 ($MILLION)
TABLE 2. GLOBAL ABDOMINAL AORTIC ANEURYSM (AAA) MARKET, BY REGION, 2017-2023 ($MILLION)
TABLE 3. GLOBAL THORACIC AORTIC ANEURYSM (TAA) MARKET, BY TYPE, 2017-2023 ($MILLION)
TABLE 4. GLOBAL ASCENDING AORTIC ANEURYSM MARKET, BY REGION, 2017-2023 ($MILLION)
TABLE 5. GLOBAL DESCENDING AORTIC ANEURYSM MARKET, BY REGION, 2017-2023 ($MILLION)
TABLE 6. GLOBAL THORACIC ARCH ANEURYSM MARKET, BY REGION, 2017-2023 ($MILLION)
TABLE 7. GLOBAL THORACIC ARCH ANEURYSM MARKET, BY REGION, 2017-2023 ($MILLION)
TABLE 8. GLOBAL ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, BY SITE, 2017-2023 ($MILLION)
TABLE 9. GLOBAL EVAR INFRARENAL SITE MARKET, BY REGION, 2017-2023 ($MILLION)
TABLE 10. GLOBAL EVAR PARARENAL SITE MARKET, BY TYPE, 2017-2023 ($MILLION)
TABLE 11. GLOBAL EVAR JUXTARENAL SITE MARKET, BY REGION, 2017-2023 ($MILLION)
TABLE 12. GLOBAL EVAR SUPRARENAL SITE MARKET, BY REGION, 2017-2023 ($MILLION)
TABLE 13. GLOBAL ENDOVADCULAR ANEURYSM REPAIR MARKET, BY ANATOMY, 2017-2023 ($MILLION)
TABLE 14. GLOBAL EVAR MARKET FOR TRADITIONAL ANATOMY, BY REGION, 2017-2023 ($MILLION)
TABLE 15. GLOBAL EVAR MARKET FOR COMPLEX ANATOMY, BY REGION, 2017-2023 ($MILLION)
TABLE 16. GLOBAL ENDOVASCULAR ANEURYSM REPAIR MARKET, BY PRODUCT, 2017-2023 ($MILLION)
TABLE 17. GLOBAL PERCUTANEOUS EVAR MARKET, BY REGION, 2017-2023 ($MILLION)
TABLE 18. GLOBAL FENESTRATED EVAR MARKET, BY REGION, 2017-2023 ($MILLION)
TABLE 19. GLOBAL EVAR MARKET FOR AORTIC STENT & TAA GRAFT, BY REGION, 2017-2023 ($MILLION)
TABLE 20. GLOBAL EVAR MARKET FOR OTHER PRODUCTS, BY REGION, 2017-2023 ($MILLION)
TABLE 21. ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, BY REGION, 2017-2023 ($MILLION)
TABLE 22. NORTH AMERICA ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, BY COUNTRY, 2017-2023 ($MILLION)
TABLE 23. NORTH AMERICA ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, BY SITE, 2017-2023 ($MILLION)
TABLE 24. NORTH AMERICA ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, BY ANATOMY, 2017-2023 ($MILLION)
TABLE 25. NORTH AMERICA ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, BY PRODUCT, 2017-2023 ($MILLION)
TABLE 26. EUROPE ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, BY COUNTRY, 2017-2023 ($MILLION)
TABLE 27. EUROPE ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, BY SITE, 2017-2023 ($MILLION)
TABLE 28. EUROPE ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, BY ANATOMY, 2017-2023 ($MILLION)
TABLE 29. EUROPE ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, BY PRODUCT, 2017-2023 ($MILLION)
TABLE 30. ASIA-PACIFIC ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, BY COUNTRY, 2017-2023 ($MILLION)
TABLE 31. ASIA-PACIFIC ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, BY SITE, 2017-2023 ($MILLION)
TABLE 32. ASIA-PACIFIC ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, BY ANATOMY, 2017-2023 ($MILLION)
TABLE 33. ASIA-PACIFIC ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, BY PRODUCT, 2017-2023 ($MILLION)
TABLE 34. LAMEA ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, BY COUNTRY, 2017-2023 ($MILLION)
TABLE 35. LAMEA ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, BY SITE, 2017-2023 ($MILLION)
TABLE 36. LAMEA ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, BY ANATOMY, 2017-2023 ($MILLION)
TABLE 37. LAMEA ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, BY PRODUCT, 2017-2023 ($MILLION)
TABLE 38. MEDTRONIC: COMPANY SNAPSHOT
TABLE 39. MEDTRONIC: OPERATING SEGMENTS
TABLE 40. COOK: COMPANY SNAPSHOT
TABLE 41. COOK: OPERATING SEGMENTS
TABLE 42. ENDOLOGIX: COMPANY SNAPSHOT
TABLE 43. ENDOLOGIX: OPERATING SEGMENTS
TABLE 44. GORE: COMPANY SNAPSHOT
TABLE 45. GORE: OPERATING SEGMENTS
TABLE 46. CARDINAL: COMPANY SNAPSHOT
TABLE 47. CARDINAL: OPERATING SEGMENTS
TABLE 48. C. R. BARD: COMPANY SNAPSHOT
TABLE 49. C. R. BARD: OPERATING SEGMENTS
TABLE 50. MERCK: COMPANY SNAPSHOT
TABLE 51. MERCK: OPERATING SEGMENTS
TABLE 52. LOMBARD: COMPANY SNAPSHOT
TABLE 53. LOMBARD: OPERATING SEGMENTS
TABLE 54. TERUMO: COMPANY SNAPSHOT
TABLE 55. TERUMO: OPERATING SEGMENTS
TABLE 56. ABBOTT: COMPANY SNAPSHOT
TABLE 57. ABBOTT: OPERATING SEGMENTS
LIST OF FIGURES
FIGURE 1. GLOBAL ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, 2016-2023
FIGURE 2. SEGMENTATION OF GLOBAL ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, 2017-2023
FIGURE 3. TOP INVESTMENT POCKETS IN GLOBAL ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, 2017-2023
FIGURE 4. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION (2014-2017)
FIGURE 5. TOP WINNING STRATEGIES: NATURE AND TYPE
FIGURE 6. TOP WINNING STRATEGIES: NATURE AND COMPANY
FIGURE 7. BARGAINING POWER OF BUYERS
FIGURE 8. BARGAINING POWER OF SUPPLIERS
FIGURE 9. THREAT OF NEW ENTRANTS
FIGURE 10. THREAT OF SUBSTITUTION
FIGURE 11. COMPETITIVE RIVALRY
FIGURE 12. RESTRAINTS AND DRIVERS: GLOBAL ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET
FIGURE 13. U.S. ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, 2017-2023 ($MILLION)
FIGURE 14. MEXICO ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, 2017-2023 ($MILLION)
FIGURE 15. U.S. ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, 2017-2023 ($MILLION)
FIGURE 16. UK ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, 2017-2023 ($MILLION)
FIGURE 17. FRANCE ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, 2017-2023 ($MILLION)
FIGURE 18. GERMANY ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, 2017-2023 ($MILLION)
FIGURE 19. ITALY ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, 2017-2023 ($MILLION)
FIGURE 20. SPAIN ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, 2017-2023 ($MILLION)
FIGURE 21. REST OF EUROPE ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, 2017-2023 ($MILLION)
FIGURE 22. INDIA ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, 2017-2023 ($MILLION)
FIGURE 23. JAPAN ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, 2017-2023 ($MILLION)
FIGURE 24. CHINA ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, 2017-2023 ($MILLION)
FIGURE 25. AUSTRALIA ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, 2017-2023 ($MILLION)
FIGURE 26. SOUTH KOREA ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, 2017-2023 ($MILLION)
FIGURE 27. THAILAND ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, 2017-2023 ($MILLION)
FIGURE 28. REST OF ASIA-PACIFIC ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, 2017-2023 ($MILLION)
FIGURE 29. BRAZIL ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, 2017-2023 ($MILLION)
FIGURE 30. REPUBLIC OF SOUTH AFRICA ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, 2017-2023 ($MILLION)
FIGURE 31. SAUDI ARABIA ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, 2017-2023 ($MILLION)
FIGURE 32. TURKEY ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, 2017-2023 ($MILLION)
FIGURE 33. REST OF LAMEA ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, 2017-2023 ($MILLION)
FIGURE 34. MEDTRONIC: NET SALES, 2014-2017 ($MILLION)
FIGURE 35. MEDTRONIC: REVENUE BY SEGMENT, 2016 (%)
FIGURE 36. MEDTRONIC: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 37. COOK: NET SALES, 2014-2017 ($MILLION)
FIGURE 38. COOK: REVENUE BY SEGMENT, 2016 (%)
FIGURE 39. COOK: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 40. ENDOLOGIX: NET SALES, 2014-2017 ($MILLION)
FIGURE 41. ENDOLOGIX: REVENUE BY SEGMENT, 2016 (%)
FIGURE 42. ENDOLOGIX: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 43. GORE: NET SALES, 2014-2017 ($MILLION)
FIGURE 44. GORE: REVENUE BY SEGMENT, 2016 (%)
FIGURE 45. GORE: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 46. CARDINAL: NET SALES, 2014-2017 ($MILLION)
FIGURE 47. CARDINAL: REVENUE BY SEGMENT, 2016 (%)
FIGURE 48. CARDINAL: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 49. C. R. BARD: NET SALES, 2014-2017 ($MILLION)
FIGURE 50. C. R. BARD: REVENUE BY SEGMENT, 2016 (%)
FIGURE 51. C. R. BARD: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 52. MERCK: NET SALES, 2014-2017 ($MILLION)
FIGURE 53. MERCK: REVENUE BY SEGMENT, 2016 (%)
FIGURE 54. MERCK: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 55. LOMBARD: NET SALES, 2014-2017 ($MILLION)
FIGURE 56. LOMBARD: REVENUE BY SEGMENT, 2016 (%)
FIGURE 57. LOMBARD: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 58. TERUMO: NET SALES, 2014-2017 ($MILLION)
FIGURE 59. TERUMO: REVENUE BY SEGMENT, 2016 (%)
FIGURE 60. TERUMO: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 61. ABBOTT: NET SALES, 2014-2017 ($MILLION)
FIGURE 62. ABBOTT: REVENUE BY SEGMENT, 2016 (%)
FIGURE 63. ABBOTT: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 1. GLOBAL ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, 2016-2023
FIGURE 2. SEGMENTATION OF GLOBAL ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, 2017-2023
FIGURE 3. TOP INVESTMENT POCKETS IN GLOBAL ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, 2017-2023
FIGURE 4. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION (2014-2017)
FIGURE 5. TOP WINNING STRATEGIES: NATURE AND TYPE
FIGURE 6. TOP WINNING STRATEGIES: NATURE AND COMPANY
FIGURE 7. BARGAINING POWER OF BUYERS
FIGURE 8. BARGAINING POWER OF SUPPLIERS
FIGURE 9. THREAT OF NEW ENTRANTS
FIGURE 10. THREAT OF SUBSTITUTION
FIGURE 11. COMPETITIVE RIVALRY
FIGURE 12. RESTRAINTS AND DRIVERS: GLOBAL ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET
FIGURE 13. U.S. ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, 2017-2023 ($MILLION)
FIGURE 14. MEXICO ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, 2017-2023 ($MILLION)
FIGURE 15. U.S. ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, 2017-2023 ($MILLION)
FIGURE 16. UK ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, 2017-2023 ($MILLION)
FIGURE 17. FRANCE ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, 2017-2023 ($MILLION)
FIGURE 18. GERMANY ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, 2017-2023 ($MILLION)
FIGURE 19. ITALY ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, 2017-2023 ($MILLION)
FIGURE 20. SPAIN ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, 2017-2023 ($MILLION)
FIGURE 21. REST OF EUROPE ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, 2017-2023 ($MILLION)
FIGURE 22. INDIA ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, 2017-2023 ($MILLION)
FIGURE 23. JAPAN ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, 2017-2023 ($MILLION)
FIGURE 24. CHINA ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, 2017-2023 ($MILLION)
FIGURE 25. AUSTRALIA ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, 2017-2023 ($MILLION)
FIGURE 26. SOUTH KOREA ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, 2017-2023 ($MILLION)
FIGURE 27. THAILAND ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, 2017-2023 ($MILLION)
FIGURE 28. REST OF ASIA-PACIFIC ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, 2017-2023 ($MILLION)
FIGURE 29. BRAZIL ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, 2017-2023 ($MILLION)
FIGURE 30. REPUBLIC OF SOUTH AFRICA ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, 2017-2023 ($MILLION)
FIGURE 31. SAUDI ARABIA ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, 2017-2023 ($MILLION)
FIGURE 32. TURKEY ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, 2017-2023 ($MILLION)
FIGURE 33. REST OF LAMEA ENDOVASCULAR ANEURYSM REPAIR (EVAR) MARKET, 2017-2023 ($MILLION)
FIGURE 34. MEDTRONIC: NET SALES, 2014-2017 ($MILLION)
FIGURE 35. MEDTRONIC: REVENUE BY SEGMENT, 2016 (%)
FIGURE 36. MEDTRONIC: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 37. COOK: NET SALES, 2014-2017 ($MILLION)
FIGURE 38. COOK: REVENUE BY SEGMENT, 2016 (%)
FIGURE 39. COOK: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 40. ENDOLOGIX: NET SALES, 2014-2017 ($MILLION)
FIGURE 41. ENDOLOGIX: REVENUE BY SEGMENT, 2016 (%)
FIGURE 42. ENDOLOGIX: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 43. GORE: NET SALES, 2014-2017 ($MILLION)
FIGURE 44. GORE: REVENUE BY SEGMENT, 2016 (%)
FIGURE 45. GORE: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 46. CARDINAL: NET SALES, 2014-2017 ($MILLION)
FIGURE 47. CARDINAL: REVENUE BY SEGMENT, 2016 (%)
FIGURE 48. CARDINAL: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 49. C. R. BARD: NET SALES, 2014-2017 ($MILLION)
FIGURE 50. C. R. BARD: REVENUE BY SEGMENT, 2016 (%)
FIGURE 51. C. R. BARD: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 52. MERCK: NET SALES, 2014-2017 ($MILLION)
FIGURE 53. MERCK: REVENUE BY SEGMENT, 2016 (%)
FIGURE 54. MERCK: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 55. LOMBARD: NET SALES, 2014-2017 ($MILLION)
FIGURE 56. LOMBARD: REVENUE BY SEGMENT, 2016 (%)
FIGURE 57. LOMBARD: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 58. TERUMO: NET SALES, 2014-2017 ($MILLION)
FIGURE 59. TERUMO: REVENUE BY SEGMENT, 2016 (%)
FIGURE 60. TERUMO: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 61. ABBOTT: NET SALES, 2014-2017 ($MILLION)
FIGURE 62. ABBOTT: REVENUE BY SEGMENT, 2016 (%)
FIGURE 63. ABBOTT: REVENUE BY GEOGRAPHY, 2016 (%)
